Michael Sheikh - Dec 31, 2022 Form 5 Insider Report for BIOXYTRAN, INC (BIXT)

Role
Chief Communication Officer
Signature
Michael Sheikh
Stock symbol
BIXT
Transactions as of
Dec 31, 2022
Transactions value $
-$19,119
Form type
5
Date filed
2/8/2023, 10:47 AM
Previous filing
May 13, 2022
Next filing
May 17, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT common Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities -$1.12K -560K -100% $0.00* 0 Dec 31, 2022 by NDPD Pharma, Inc. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIXT warrant Gift -$18K -50K -100% $0.36 0 May 13, 2022 common 50K $2.00 by NDPD Pharma, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 ownership of BIXT by NDPD Pharma, Inc. is consolidated under indirect ownership inside Davis Platt's filing